Today, Lumen Bioscience reported that its investigational oral biologic, LMN-201, achieved a 100% clinical cure

April 3, 2025 No Comments

The shift toward Bayesian dosing is transforming how hospitals manage antimicrobial therapy, particularly for medications

April 3, 2025 No Comments

Image credit: Alexander Grey A large study highlights central venous catheters, respiratory support, urinary catheters,

April 2, 2025 No Comments

Marc Ka-Chun Chong, PhD Image credits: CCRB A recent study analyzing the impact of nirmatrelvir/ritonavir

April 2, 2025 No Comments

Captured on the 5th day of this illness, this photograph depicted a posterior view of

April 2, 2025 No Comments

Researchers are advancing the development of a novel immunotherapy for mucormycosis, a rare and often

April 2, 2025 No Comments

As we enter the second quarter of 2025, the FDA is reviewing treatments in infectious

April 1, 2025 No Comments

Today, the World Health Organization (WHO) announced it had published 2 reports regarding therapies and

April 1, 2025 No Comments

Researchers have developed VX-01, a humanized monoclonal antibody designed to target mucormycosis, a severe fungal

April 1, 2025 No Comments

Researchers have developed VX-01, a humanized monoclonal antibody designed to target mucormycosis, a severe fungal

March 31, 2025 No Comments

Schedule an Appointment

Quick Links